Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Nurse urges Vermont lawmakers to restore medical oversight and tougher testing for hemp-derived delta-9 products
Summary
A registered nurse told a Senate Agriculture committee that hemp-derived delta-9 products lack contaminant testing and that the state should reinstate a Symptom Relief Oversight Committee to give patients and medical professionals a formal voice on qualifying conditions and safety rules.
Jessie Lynn Dolan, a registered nurse and longtime cannabis program participant, told the Senate Committee on Agriculture that patient safety and education should be central to how Vermont regulates hemp-derived delta-9 products and adult-use cannabis. She urged lawmakers to reestablish the Symptom Relief Oversight Committee and to require the same contaminant testing for hemp-derived delta-9 that the Cannabis Control Board requires for high-THC cannabis.
Dolan said many people use cannabis for symptom relief rather than to get high and warned that dosing for engineered hemp-derived delta-9 can be potent. "One to…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
